, Volume 113, Issue 3–4, pp 565–569 | Cite as

Anxiolytic effect of glycine antagonists microinjected into the dorsal periaqueductal grey

  • M. G. Matheus
  • R. L. Nogueira
  • A. P. Carobrez
  • F. G. Graeff
  • F. S. Guimarães
Original Investigations


To investigate if blockade of the modulatory glycine site of NMDA receptors in the dorsal periaqueductal grey (DPAG) would produce anxiolytic effects, groups of 9–14 rats received microinjections into this structure of 7-chloro-kynurenic acid (7-Cl-KY, 4 and 8 nmol) or 3-amino-1-hydroxypyrrolid-2-one (HA-966, 30 or 100 nmol), two selective antagonists at the strychnine-insensitive glycine modulatory site, and were submitted to the elevated plus-maze, an ethologically based animal model of anxiety. Both drugs increased the percentage of entries and of time spent in open arms as compared to rats receiving isotonic saline. Injections of the active compounds outside the DPAG were not effective. In another experiment microinjections of 7-Cl-KY (8 nmol) and HA-966 (100 nmol) into the DPAG raised the threshold of aversive electrical stimulation of the rat DPAG. These results indicate that microinjections of 7-Cl-KY and HA-966 into the DPAG cause anxiolytic effects in two different models of anxiety and support the proposal that NMDA-mediated neurotransmission in the DPAG may be related to anxiety and panic.

Key words

Excitatory amino acids Dorsal periaqueductal grey NMDA receptor Strychnine-insensitive glycine receptor antagonists Anxiolytic effect Elevated plus-maze Aversive brain stimulation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Audi EA, de Oliveira CE, Graeff FG (1989) Serotonergic mediation of the anxiolytic effect of intracerebrally injected propranolol measured in the elevated plus-maze. Braz J Med Biol Res 22:699–701PubMedGoogle Scholar
  2. Audi EA, Graeff FG (1984) Benzodiazepine receptors in the periaqueductal grey mediate antiaversive drug action. Eur J Pharmacol 103:279–285CrossRefPubMedGoogle Scholar
  3. Bandler R (1984) Identification of hypothalamic and midbrain periaqueductal grey neurones mediating aggressive and defensive behaviour by microinjections of excitatory amino acids. In: Bandler R (ed) Modulation of sensorimotor activity during alterations in behavioral states. Liss, New York, pp 369–391Google Scholar
  4. Beart PM, Nicolopoulos LS, West DC, Headley PM (1988) An excitatory amino acid projection from ventromedial hypothalamus to periaqueductal gray in the rat: autoradiographic and electrophysiological evidence. Neurosci Lett 85:205–211CrossRefPubMedGoogle Scholar
  5. Beart PM, Summers RJ, Stephenson JA, Cook CJ, Christie MJ (1990) Excitatory projections to the periaqueductal gray in the rat: a retrograde transport study utilizing d[3H]GABA. Neuroscience 34:163–176CrossRefPubMedGoogle Scholar
  6. Beitz AJ (1989) Possible origin of glutamatergic projections to the midbrain periaqueductal gray and deep layer of the superior colliculus of the rat. Brain Res Bull 23:25–35CrossRefPubMedGoogle Scholar
  7. Brugger F, Wicki U, Nassenstein-Elton D, Fagg GE, Olpe H-R, Pozza MF (1990) Modulation of the NMDA receptor by D-serine in the cortex and the spinal cord, in vitro. Eur J Pharmacol 191:29–38CrossRefPubMedGoogle Scholar
  8. Carobrez AP (1987) Excitatory amino acid mediation of the defence reaction. In: Brandão ML (ed) Neurosciences and behavior. UFES-Grafica, Vitória, Brazil, pp 21–29Google Scholar
  9. Cavalheiro EAA, Lehman J, Turski L (1988) Frontiers in excitatory amino acid research. Liss, New YorkGoogle Scholar
  10. Corbett R, Dunn RW (1991) Effects of HA-966 on conflict, social interaction, and plus maze behaviors. Drug Dev Res 24 24:201–203CrossRefGoogle Scholar
  11. Danysz W, Fadda E, Wroblewski JT, Costa E (1990) [3H] D-serine labels strychnine-insensitive glycine recognition sites of rat central nervous system. Life Sci 46:115–164CrossRefGoogle Scholar
  12. Dunn RW, Corbett R, Fielding S (1989) Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 169:1–10CrossRefPubMedGoogle Scholar
  13. File SE (1992) Behavioural detection of anxiolytic action. In: Elliott JM, Heal DJ, Marsden CA (eds) Experimental approaches to anxiety and depression. Wiley, New York, pp 25–44Google Scholar
  14. Fletcher EJ, Millar JD, Lodge D (1989) Non-competitive antagonism of N-methyl-D-aspartate by displacement of an endogenous glycine-like substance. Eur J Neurosci 1:196–203PubMedGoogle Scholar
  15. Foster AC, Willis CL, Tridgett R (1990) Protection against N-methyl-D-aspartate receptor mediated neuronal degeneration in rat brain by 7-chlorokynurenate and 3-amino-1-hydroxypyrrolid-2-one, antagonists at the allosteric site for glycine. Eur J Neurosci 2:270–277PubMedGoogle Scholar
  16. Graeff FG (1990) Brain defence system and anxiety. In Roth M, Burrows GD, Nogyes R (eds) Handbook of anxiety, vol 3. Elsever, Amsterdam, pp 307–354Google Scholar
  17. Graeff FG (1991) Neurotransmitters in the dorsal periaqueductal grey and animal models of panic anxiety. In: Briley M, File SE (eds) New concepts in anxiety. Macmillan, London, pp 288–312Google Scholar
  18. Graeff FG, Carobrez AP, Silveira MCL (1988) Excitatory amino acids and the brain aversive system. In: Cavalheiro EA, Lehman J, Turski L (eds) Frontiers in excitatory amino acids research. Liss, New York, pp 325–332Google Scholar
  19. Guimarães FS, Carobrez AP, de Aguiar JC, Graeff FG (1991) Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology 103:91–94PubMedGoogle Scholar
  20. Johnson JW, Ascher P (1987) Glycine potentiates the NMDA responses in cultured mouse brain neurones. Nature 325:529–531CrossRefPubMedGoogle Scholar
  21. Kehne JH, McCloskey TC, Baron BM, Chi EM, Harrison BL, Whitten JP, Palfreyman MG (1991) NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations. Eur J Pharmacol 193:283–292CrossRefPubMedGoogle Scholar
  22. Kloog Y, Lamdani-Itkin H, Sokolovsky M (1990) The glycine site of the N-methyl-D-aspartate receptor channel: differences between the binding of HA-966 and of 7-chlorokynurenic acid. J Neurochem 54:1576–1583PubMedGoogle Scholar
  23. Krieger JE, Graeff FG (1985) Defensive behavior and hypertension induced by glutamate in the midbrain central gray of the rat. Braz J Med Biol Res 18:61–67PubMedGoogle Scholar
  24. Lu C-L, Shaikh MB, Siegel A (1992) Role of NMDA receptors in hypothalamic facilitation of feline defensive rage elicited from the midbrain periaqueductal gray. Brain Res 581:123–132CrossRefPubMedGoogle Scholar
  25. Nashold BS Jr, Wilson NP, Slaughter GS (1974) The midbrain and pain. In: Bonica JJ (ed) Advances in neurology, vol 4: International symposium on pain. Raven press, New York, pp 191–196Google Scholar
  26. Nogueira RL, Graeff FG (1991) 5-HT mediation of the antiaversive effect of isamoltane injected into the dorsal periaqueductal grey. Behav Pharmacol 2:73–77PubMedGoogle Scholar
  27. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, second edition. Academic Press, San DiegoGoogle Scholar
  28. Pellow S, Chopin P, File SE, Briley M (1985) Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167CrossRefPubMedGoogle Scholar
  29. Pittaluga A, Raiteri M (1990) Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur J Pharmacol 191:231–234CrossRefPubMedGoogle Scholar
  30. Porter JH, Wiley JL, Balster RL (1989) Effects of phencyclidine-like drugs on punished behavior in rats. J Pharmacol Exp Ther 248:997–1002PubMedGoogle Scholar
  31. Russo AS, Guimaràes FS, de Aguiar JC, Graeff FG (1993) Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety. Psychopharmacology 110:198–202PubMedGoogle Scholar
  32. Schmitt P, Di Scala G, Brandão ML, Karli P (1984) Periventricular structures, elaboration of aversive effects and processing of sensory information. In: Bandler R (ed) Modulation of sensorimotor activity during alterations in behavioral states. Liss, New York, pp 393–414Google Scholar
  33. Stephens DN, Meldrum BS, Weidmann R, Schneider C, Grutzner M (1986) Does the excitatory amino-acid receptor antagonist 2-APH exhibit anxiolytic activity? Psychopharmacology 90:166–169Google Scholar
  34. Trullas R, Jackson B, Skolnick P (1989) Anxiolytic properties of 1-aminocyclopropanecarboxylic acid, a ligand at strychnine-insensitive glycine receptors. Pharmacol Biochem Behav 34:313–316CrossRefPubMedGoogle Scholar
  35. Trullas R, Folio T, Young A, Miller R, Boje K, Skolnick P (1991) 1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models. Eur J Pharmacol 203:379–385CrossRefPubMedGoogle Scholar
  36. Vartanian MG, Taylor CP (1991) Different stereoselectivity of the enantiomers of HA-966 (3-amino-1-hydroxy-2-pyrrolidine) for neuroprotective and anticonvulsant actions in vivo. Neurosci Lett 133:109–112CrossRefPubMedGoogle Scholar
  37. Young AB, Fagg GE (1990) Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches TIPS 11:126–132Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • M. G. Matheus
    • 1
  • R. L. Nogueira
    • 3
  • A. P. Carobrez
    • 2
  • F. G. Graeff
    • 3
  • F. S. Guimarães
    • 1
  1. 1.Department of PharmacologyFMRP, Campus USPRibeirão Preto, SPBrazil
  2. 2.Department of PharmacologyBiological Sciences Centre, UFSCFlorianópolis, SCBrazil
  3. 3.Laboratory of PsychobiologyFFCLRP, Campus USPRibeirão Preto, SPBrazil

Personalised recommendations